Results 21 to 30 of about 401,280 (164)

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии, 2019
Aim. Clinical guidelines for the management of adult patients suffering from drug-induced liver injuries (DILI) are intended for all medical specialists, who treat such patients in their clinical practice.Key findings.
Vladimir T. Ivashkin   +8 more
doaj   +1 more source

Case series and review of Ayurvedic medication induced liver injury

open access: yesBMC Complementary Medicine and Therapies, 2021
Background Complementary and alternative medicine use among Americans is prevalent. Originating in India, Ayurvedic medicine use in the United States has grown 57% since 2002.
Christopher M. Karousatos   +3 more
doaj   +1 more source

Treatment with gefitinib after erlotinib-induced liver injury: a case report [PDF]

open access: yes, 2011
INTRODUCTION: Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains unclear whether the hepatotoxicity induced by one compound is affected by the other.
Iida Tetsuya   +3 more
core   +2 more sources

Rational choice of hepatoprotectors for drug-induced liver injury

open access: yesGastroenterologìa, 2022
The article deals with a review of the current literature on the clinical use of hepatoprotectors in drug-induced liver injury. The literature was searched in Scopus, Web of Science, PubMed and other databases. Risk factors, pathogenetic mechanisms of li­
H.V. Osyodlo   +2 more
doaj   +1 more source

Febuxostat-induced acute liver injury [PDF]

open access: yes, 2016
Febuxostat is a unique xanthine oxidase inhibitor that was approved for the prevention of gout in the United States in 2009. Unlike allopurinol, febuxostat is not a nucleoside analogue and has a higher specificity for xanthine oxidase. Although this drug
Matt Bohm   +3 more
core   +2 more sources

Dietary Intake of Vegetables and Cooking Oil Was Associated With Drug-Induced Liver Injury During Tuberculosis Treatment: A Preliminary Cohort Study

open access: yesFrontiers in Nutrition, 2021
Background and Purpose: Drug-induced liver injury is challenging during tuberculosis treatment. There is no epidemiological data investigating the relation between dietary intake and the risk of drug-induced liver injury during tuberculosis treatment ...
Jinyu Wang   +6 more
doaj   +1 more source

Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment

open access: yesAnnals of Hepatology, 2019
Introduction and aim: Epidemiological information regarding drug-induced liver injury in some Latin American countries remains limited. Therefore, disease prevention and health promotion strategies are imperative to reduce drug-induced liver injuries and
Alejandra Cano-Paniagua   +3 more
doaj   +1 more source

A four-month gatifloxacin-containing regimen for treating tuberculosis. [PDF]

open access: yes, 2014
BACKGROUND: Shortening the course of treatment for tuberculosis would be a major improvement for case management and disease control. This phase 3 trial assessed the efficacy and safety of a 4-month gatifloxacin-containing regimen for treating rifampin ...
Amukoye, Evans   +19 more
core   +1 more source

Insuficiência Hepática Aguda Induzida pela Trazodona e Diazepam [PDF]

open access: yes, 2016
Most antidepressant agents have the potential to cause liver injury, even at therapeutic doses. Nevertheless, drug-induced liver injury (DILI) from antidepressant agents is a rare event. There is no way to prevent idiopathic DILI, but the severity of the
Barroso, E   +5 more
core   +1 more source

Ivermectin drug induced liver injury

open access: yesSouth African Medical Journal, 2023
Ivermectin remains a popular, albeit unproven, therapy used in both the prevention and treatment of COVID-19. We discuss a patient who developed jaundice and a liver injury 3 weeks after initiating ivermectin for COVID prevention.
Mark Sonderup   +2 more
doaj  

Home - About - Disclaimer - Privacy